Stock-Based Compensation Expense (Tables)

9 Months Ended

Sep. 30, 2022

Shares Granted or Issued, Share-Based Payment Arrangement [Abstract]

Schedule of stock options vested and exercisable

	Shares			Weighted- average exercise price		Weighted- average remaining contractual term (years)		Aggregate intrinsic value
Outstanding as of December 31, 2021		8,769,694		$	1.20		7.15	$	15,746,916
Granted		1,901,500			1.76		-		-
Exercised		(717,041	)		0.16		-		1,012,175
Cancelled/forfeited		(136,709	)		2.79		-		-
Outstanding as of September 30, 2022		9,817,444		$	1.36		7.09	$	4,217,271
Vested and expected to vest at September 30, 2022		9,817,444		$	1.36		7.09	$	4,217,271
Vested and exercisable at September 30, 2022		5,962,393		$	0.64		5.73	$	4,175,407

Schedule of restricted stock units and activity

	Shares			Weighted- average grant date fair value
Unvested shares at December 31, 2021		-		$	-
RSUs granted		244,566			5.52
RSUs vested		(16,302	)		5.52
RSUs forfeited		-			-
Unvested Shares at September 30, 2022		228,264		$	5.52

Schedule of weighted average fair value of each grant estimated on grant date

	Nine Months Ended September 30,
	2022			2021
Fair value of common stock	$	1.76		$	-
Expected term (in years)		6.05			-
Risk-free rate		2.6	%		-	%
Expected volatility		40.3	%		-	%
Dividend yield		-	%		-	%